| Affiliation auteurs | !!!! Error affiliation !!!! |
| Titre | Final overall survival (OS) analysis of PROfound: Olaparib vs physician's choice of enzalutamide or abiraterone in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) and homologous recombination repair (HRR) gene alterations |
| Type de publication | Journal Article |
| Year of Publication | 2020 |
| Auteurs | de Bono J.S, Mateo J., Fizazi K., Saad F., Shore N., Sandhu S., Chi K.N, Sartor O., Agarwal N., Olmos D., Thiery-Vuillemin A., Twardowski P., Roubaud G., Ozguroglu M., Kang J., Burgents J., Gresty C., Corcoran C., Adelman C.A, Hussain M. |
| Journal | ANNALS OF ONCOLOGY |
| Volume | 31 |
| Pagination | S508 |
| Date Published | SEP |
| Type of Article | Meeting Abstract |
| ISSN | 0923-7534 |
| DOI | 10.1016/j.annonc.2020.08.870 |
